About Medizinische Hochschule; Zentrum Innere Medizin; Abt. Hämatologie u. Onkologie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Medizinische Hochschule; Zentrum Innere Medizin; Abt. Hämatologie u. Onkologie
During the past decade, Medizinische Hochschule; Zentrum Innere Medizin; Abt. Hämatologie u. Onkologie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on
average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Medizinische Hochschule; Zentrum Innere Medizin; Abt. Hämatologie u. Onkologie" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Alexion" with 3 trials
sponsored, "BioNTech Cell & Gene Therapies GmbH" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "University of Jena"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at Medizinische Hochschule; Zentrum Innere Medizin; Abt. Hämatologie u. Onkologie
According to Clinical.Site data, the most researched conditions in "Medizinische Hochschule; Zentrum Innere Medizin; Abt. Hämatologie u. Onkologie" are
"Hemoglobinuria, Paroxysmal" (2 trials), "Renal Cell Carcinoma" (2 trials), "Chronic Myeloid Leukemia" (1 trials), "Colorectal Cancer" (1 trials) and "Gastric Cancer" (1 trials). Many other conditions were trialed in "Medizinische Hochschule; Zentrum Innere Medizin; Abt. Hämatologie u. Onkologie" in a lesser frequency.
Clinical Trials Intervention Types at Medizinische Hochschule; Zentrum Innere Medizin; Abt. Hämatologie u. Onkologie
Most popular intervention types in "Medizinische Hochschule; Zentrum Innere Medizin; Abt. Hämatologie u. Onkologie" are "Drug" (11 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "eculizumab" (3 trials), "Atezolizumab" (2 trials), "Bevacizumab" (2 trials) and "5-FU/LV" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Medizinische Hochschule; Zentrum Innere Medizin; Abt. Hämatologie u. Onkologie
The vast majority of trials in "Medizinische Hochschule; Zentrum Innere Medizin; Abt. Hämatologie u. Onkologie" are
12 trials for "All" genders.
Clinical Trials Status at Medizinische Hochschule; Zentrum Innere Medizin; Abt. Hämatologie u. Onkologie
Currently, there are NaN active trials in "Medizinische Hochschule; Zentrum Innere Medizin; Abt. Hämatologie u. Onkologie".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Medizinische Hochschule; Zentrum Innere Medizin; Abt. Hämatologie u. Onkologie,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Medizinische Hochschule; Zentrum Innere Medizin; Abt. Hämatologie u. Onkologie, 2 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".